Literature DB >> 15752776

LARGE2 facilitates the maturation of alpha-dystroglycan more effectively than LARGE.

Katsuya Fujimura1, Hiromichi Sawaki, Tokiko Sakai, Toru Hiruma, Nobuo Nakanishi, Takashi Sato, Takashi Ohkura, Hisashi Narimatsu.   

Abstract

The LARGE gene is thought to encode a putative glycosyltransferase because of its typical topology. However, no enzyme activity has been demonstrated yet, although the gene apparently supports the functional maturation of alpha-dystroglycan by glycosylation when it is transfected into cells. A novel homologous gene to LARGE was identified and named LARGE2. LARGE2 recombinant was co-expressed with alpha-dystroglycan in human embryonic kidney 293T cells to determine its activity to support the maturation of alpha-dystroglycan. The alpha-dystroglycan co-transfected with LARGE2 was more highly glycosylated than that co-transfected with LARGE. Pull-down experiments demonstrated binding activity of LARGE2 as well as LARGE toward alpha-dystroglycan. LARGE2 was found to support the maturation of alpha-dystroglycan more effectively than LARGE. Both of them are ubiquitously expressed in many tissues, except the brain where LARGE2 was not expressed at all. This compensatory function can explain the residual functionally glycosylated alpha-dystroglycan in a patient with MDC1D whose LARGE genes are congenitally null.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15752776     DOI: 10.1016/j.bbrc.2005.02.082

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

1.  Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase.

Authors:  Peng Zhang; Huaiyu Hu
Journal:  Glycobiology       Date:  2011-09-19       Impact factor: 4.313

2.  LARGE, an intellectual disability-associated protein, regulates AMPA-type glutamate receptor trafficking and memory.

Authors:  Bo Am Seo; Taesup Cho; Daniel Z Lee; Joong-Jae Lee; Boyoung Lee; Seong-Wook Kim; Hee-Sup Shin; Myoung-Goo Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-18       Impact factor: 11.205

Review 3.  Mammalian O-mannosylation: unsolved questions of structure/function.

Authors:  Stephanie H Stalnaker; Ryan Stuart; Lance Wells
Journal:  Curr Opin Struct Biol       Date:  2011-09-22       Impact factor: 6.809

Review 4.  Mechanisms of disease: congenital muscular dystrophies-glycosylation takes center stage.

Authors:  Paul T Martin
Journal:  Nat Clin Pract Neurol       Date:  2006-04

Review 5.  Protein O-mannosylation in animal development and physiology: from human disorders to Drosophila phenotypes.

Authors:  Naosuke Nakamura; Dmitry Lyalin; Vladislav M Panin
Journal:  Semin Cell Dev Biol       Date:  2010-04-01       Impact factor: 7.727

6.  The glycosyltransferase LARGE2 is repressed by Snail and ZEB1 in prostate cancer.

Authors:  Qin Huang; Michael R Miller; James Schappet; Michael D Henry
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 7.  The genetic and molecular basis of muscular dystrophy: roles of cell-matrix linkage in the pathogenesis.

Authors:  Motoi Kanagawa; Tatsushi Toda
Journal:  J Hum Genet       Date:  2006-09-13       Impact factor: 3.172

Review 8.  The dystroglycanopathies: the new disorders of O-linked glycosylation.

Authors:  Paul T Martin
Journal:  Semin Pediatr Neurol       Date:  2005-09       Impact factor: 1.636

9.  Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer.

Authors:  Alison K Esser; Michael R Miller; Qin Huang; Melissa M Meier; Daniel Beltran-Valero de Bernabé; Christopher S Stipp; Kevin P Campbell; Charles F Lynch; Brian J Smith; Michael B Cohen; Michael D Henry
Journal:  J Biol Chem       Date:  2012-12-06       Impact factor: 5.157

10.  Adeno-associated viral-mediated LARGE gene therapy rescues the muscular dystrophic phenotype in mouse models of dystroglycanopathy.

Authors:  Miao Yu; Yonglin He; Kejian Wang; Peng Zhang; Shengle Zhang; Huaiyu Hu
Journal:  Hum Gene Ther       Date:  2013-03       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.